Expert Interview
Discussing Gossamer Bio's Phase 3 PROSERA Study in advance of the topline data in February evaluating seralutinib in PAH
Ticker(s): GOSSInstitution: UCLA School of Medicine
- Professor of Medicine and Pulmonology at UCLA
- Medical Director of the Lung Institute at Cedars Sinai who has experience managing patients with the Zephyr and Spiration valve. Sees 200 patients with COPD and emphysema
- Research interest in pulmonary exercise physiology, hyperinflation, emphysema and non-invasive lung volume reduction in emphysema.
What are your preferred treatments for PAH?
Added By: wilson_adminLikelihood of topline success for PROSERA?
Added By: wilson_adminHow would you envision using seralutinib if approved?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
